EUVIMEDEUVIMED entdecken
Crossref

Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia

S Holmes iD, L K Hornberger, E Jaeggi iD, L Howley iD, A J Moon-Grady, O Uzun, A Kaizer, O Gilicze, B F Cuneo iD

Ultrasound in Obstetrics & Gynecology · 2023

DOI: 10.1002/uog.26239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2023. Verfasst von S Holmes und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Heart Institute, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA. Hauptthemen laut MEDLINE: Atrial Flutter, Fetal Diseases, Tachycardia, Supraventricular. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

While in‐utero treatment of sustained fetal supraventricular arrhythmia (SVA) is standard practice in the previable and preterm fetus, data are limited on best practice for late preterm (34 + 0 to 36 + 6 weeks), early term (37 + 0 to 38 + 6 weeks) and term (> 39 weeks) fetuses with SVA. We reviewed the delivery and postnatal outcomes of fetuses at ≥ 35 weeks of gestation undergoing treatment rather than immediate delivery.

Methods

This was a retrospective case series of fetuses presenting at ≥ 35 weeks of gestation with sustained SVA and treated transplacentally at six institutions between 2012 and 2022. Data were collected on gestational age at presentation and delivery, SVA diagnosis (short ventriculoatrial (VA) tachycardia, long VA tachycardia or atrial flutter), type of antiarrhythmic medication used, interval between treatment and conversion to sinus rhythm and postnatal SVA recurrence.

Results

Overall, 37 fetuses presented at a median gestational age of 35.7 (range, 35.0–39.7) weeks with short VA tachycardia ( n = 20), long VA tachycardia ( n = 7) or atrial flutter ( n = 10). Four (11%) fetuses were hydropic. In‐utero treatment led to restoration of sinus rhythm in 35 (95%) fetuses at a median of 2 (range, 1–17) days; this included three of the four fetuses with hydrops. Antiarrhythmic medications included flecainide ( n = 11), digoxin ( n = 7), sotalol ( n = 11) and dual therapy ( n = 8). Neonates were liveborn at 36–41 weeks via spontaneous vaginal delivery (23/37 (62%)) or Cesarean delivery (14/37 (38%)). Cesarean delivery was indicated for fetal SVA in two fetuses, atrial ectopy or sinus bradycardia in three fetuses and obstetric reasons in nine fetuses that were in sinus rhythm at the time of delivery. Twenty‐one (57%) cases were treated for recurrent SVA after birth.

Conclusion

In‐utero treatment of the near term and term (≥ 35‐week) SVA fetus is highly successful even in the presence of hydrops, with the majority of cases delivered vaginally closer to term, thereby avoiding unnecessary Cesarean section. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FlutterFetal DiseasesTachycardia, SupraventricularFemaleHumansInfantInfant, NewbornPregnancyAnti-Arrhythmia AgentsCesarean SectionDigoxinEdemaFetusHydrops FetalisRetrospective StudiesTachycardia

Stichwörter der Autor:innen

Cesarean deliveryfetal arrhythmiafetal echocardiographyfetal tachycardiaprenatal treatment

Substanzen

Anti-Arrhythmia AgentsDigoxin

Autor:innen und Institutionen

  • The Heart Institute, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA.
  • Division of Cardiology, Department of Pediatrics, Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.
  • Division of Cardiology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Children's Hospital Minnesota, Minneapolis, MN, USA.
  • University of California San Francisco, San Francisco, CA, USA.
  • School of Medicine and University Hospital of Wales, Cardiff, UK.

ORCID-Profile: S Holmes, E Jaeggi, L Howley, B F Cuneo

Zitieren

APA

Holmes, S., Hornberger, L. K., Jaeggi, E., Howley, L., Moon-Grady, A. J., Uzun, O., Kaizer, A., Gilicze, O., & Cuneo, B. F. (2023). Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.26239

Vancouver

Holmes S, Hornberger LK, Jaeggi E, Howley L, Moon-Grady AJ, Uzun O, et al. Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia. Ultrasound in Obstetrics & Gynecology. 2023. doi:10.1002/uog.26239

BibTeX
@article{Holmes2023,
  author = {Holmes, S and Hornberger, L K and Jaeggi, E and Howley, L and Moon-Grady, A J and Uzun, O and Kaizer, A and Gilicze, O and Cuneo, B F},
  title = {Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2023},
  doi = {10.1002/uog.26239}
}
Kostenlos starten →